首页|Fujian Medical University Reports Findings in Rectal Cancer (Com- parative analysis of preoperative chemoradiotherapy and upfront surgery in the treatment of upper-half rectal cancer: oncological benefits, surgical outcomes, and cost implications)
Fujian Medical University Reports Findings in Rectal Cancer (Com- parative analysis of preoperative chemoradiotherapy and upfront surgery in the treatment of upper-half rectal cancer: oncological benefits, surgical outcomes, and cost implications)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
2024 FEB 02 (NewsRx) – By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Oncology - Rectal Cancer is the subject of a report. According to news reporting originating in Fujian, People’s Republic of China, by NewsRx journalists, research stated, “The value of neoadjuvant chemoradiotherapy (CRT) is not absolutely clear for upper-half (＞7-15 cm) rectal cancer. This study aimed to compare the efficacy and safety of radical surgery with preoperative CRT vs. upfront surgery (US) in Chinese patients with stage Ⅱ and Ⅲ upper-half rectal cancer.”
FujianPeople’s Republic of ChinaAsiaCancerDrugs and TherapiesEmerging TechnologiesGastroenterologyHealth and MedicineMachine LearningOncologyRectal CancerRisk and PreventionRoboticsRobotsSurgery
NETL
NSTL
